FreshTracks Capital — 2023 Investments
2 investments dated 2023 · listed companies and verified rows first · show all
DataBlend, Inc.Jun 2023SEC filingmedium confidence
Stowe, US
Board seatLee Bouyea· per SEC Form D · $2.6M raise · filed Jun 2024
Aprexisaprexis.comSep 2023
Aprexis offers a platform for medication therapy management (MTM) and customizable clinical programs covering lifestyle medicine and disease management, using AI-driven patient stratification, a patient-facing mobile app, and EHR interoperability.
Digital HealthHealthtechSaaS
MICHAEL HOWE(Executive Officer)ROBERT SQUIRE(Director)
PartnerLee Bouyea· led
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.